Neurodegenerative Disorders
A New Hope for Alzheimer’s Patients Arrives at the Start of 2023
Lecanemab, a new Alzheimer’s medication, has been approved by the FDA, coming at half the price of Aduhelm, released in 2021.
This post summarizes the impact and implications of recent critical health news and provides tips for lowering the risk of Alzheimer’s.
By understanding the latest developments in the field of health and wellness, you can make informed decisions about how to protect and improve your brain and mental health.
My goal is to inform and inspire you to take proactive steps to lower your risk of developing Alzheimer’s and other neurodegenerative disorders with lifestyle choices and support from qualified healthcare professionals.
Noteworthy progress from 2021 to 2023
In 2021 I wrote an article when FDA approved Aduhelm, which was a unique drug at the time. It was developed and marketed by Biogen. But Aduhelm created concerns from an economic perspective as it needed to be cheaper to start with.
The price was $56,000 per year. Thousands of underprivileged people couldn’t afford it. This health equity issue created…
